Better Efficacy
■ Covers gram positive & gram negative pathogens

■ Provides better antimicrobial action than Cefixime against respiratory pathogens

Better Safety & Tolerability

■ Well tolerated by patients of all age group Found to cause minimum adverse events
Better than Co-amoxiclav 

■ In treatment of Sinusitis, Oral Cefpodoxime found to be better compared to Co-amoxiclav